최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of chemical neuroanatomy, v.106, 2020년, pp.101792 -
Borhani-Haghighi, Maryam (Department of Anatomy, School of Medicine, Tehran University of Medical Sciences) , Mohamadi, Yousef (Department of Anatomy, School of Medicine, Ilam University of Medical Sciences)
Abstract In multiple sclerosis, myelin sheaths around the axons are degenerated due to uncontrolled inflammation in the central nervous system. Oligodendrocytes (OLs) are myelin-forming cells that secrete trophic factors necessary for myelin protection. Beneficial features of conditioned medium (CM...
Future Neurol. Armstrong 2 6 689 2007 10.2217/14796708.2.6.689 Growth factor regulation of remyelination: behind the growing interest in endogenous cell repair of the CNS
Int. Immunopharmacol. Aryanpour 51 131 2017 10.1016/j.intimp.2017.08.007 Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model
Neurosci. Bull. Bankston 29 2 216 2013 10.1007/s12264-013-1321-3 Oligodendroglia and neurotrophic factors in neurodegeneration
J. Neuroinflammation Bovolenta 7 1 81 2010 10.1186/1742-2094-7-81 Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures
Stroke Chen 32 4 1005 2001 10.1161/01.STR.32.4.1005 Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats
Cell Transplant. Cheng 26 3 469 2017 10.3727/096368916X693473 Neural stem cell-conditioned medium suppresses inflammation and promotes spinal cord injury recovery
CNS Neurosci. Ther. Dahbour 23 11 866 2017 10.1111/cns.12759 Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: clinical, ophthalmological and radiological assessments of safety and efficacy
J. Neurosci. Dai 23 13 5846 2003 10.1523/JNEUROSCI.23-13-05846.2003 The trophic role of oligodendrocytes in the basal forebrain
Curr. Opin. Neurol. De Feo 25 3 322 2012 10.1097/WCO.0b013e328352ec45 Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection
Brain De Stefano 121 8 1469 1998 10.1093/brain/121.8.1469 Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
J. Neurosci. Res. Dell’Albani 54 2 191 1998 10.1002/(SICI)1097-4547(19981015)54:2<191::AID-JNR7>3.0.CO;2-9 Oligodendroglial survival factors, PDGFAA and CNTF, activate similar JAK/STAT signaling pathways
Stem Cell Rep. Douvaras 3 2 250 2014 10.1016/j.stemcr.2014.06.012 Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells
J. Neurosci. Res. Du 68 6 647 2002 10.1002/jnr.10245 Oligodendrocytes as providers of growth factors
J. Neuroimmunol. Duchi 258 1-2 32 2013 10.1016/j.jneuroim.2013.02.013 Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis
Int. J. Mol. Sci. Fletcher 19 12 4131 2018 10.3390/ijms19124131 Brain-derived neurotrophic factor in central nervous system myelination: a new mechanism to promote myelin plasticity and repair
J. Alzheimer Dis. Gelfo 25 2 213 2011 10.3233/JAD-2011-110047 Brain and serum levels of nerve growth factor in a rat model of Alzheimer’s disease
Dev. Neurosci. Gumpel 11 2 132 1989 10.1159/000111894 Myelination and remyelination in the central nervous system by transplanted oligodendrocytes using the shiverer model
Mol. Ther. Methods Clin. Dev. Irion 4 72 2017 10.1016/j.omtm.2016.11.005 Bringing neural cell therapies to the clinic: past and future strategies
Brain Res. Jahan-Abad 1711 226 2019 10.1016/j.brainres.2019.01.035 Therapeutic potential of conditioned medium derived from oligodendrocytes cultured in a self-assembling peptide nanoscaffold in experimental autoimmune encephalomyelitis
Brain Res. Jahan-Abad 2019 Therapeutic potential of conditioned medium derived from oligodendrocytes cultured in a self-assembling peptide nanoscaffold in experimental autoimmune encephalomyelitis
Biomed. Res. Int. Kalaszczynska 2015 430847 2015 10.1155/2015/430847 Wharton’s jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance
J. Neurol. Sci. Lassmann 259 1-2 3 2007 10.1016/j.jns.2006.08.016 Multiple sclerosis: is there neurodegeneration independent from inflammation?
PLoS One Leite 9 10 e111059 2014 10.1371/journal.pone.0111059 Differentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage
Glia Liu 66 12 2575 2018 10.1002/glia.23512 Distinct patterns of glia repair and remyelination in antibodymediated demyelination models of multiple sclerosis and neuromyelitis optica
Nat. Rev. Neurol. Martino 6 5 247 2010 10.1038/nrneurol.2010.35 Stem cell transplantation in multiple sclerosis: current status and future prospects
J. Neurosci. Miyamoto 35 41 14002 2015 10.1523/JNEUROSCI.1592-15.2015 Astrocytes promote oligodendrogenesis after white matter damage via brain-derived neurotrophic factor
J. Chem. Neuroanat. Mohamadi 97 1 2019 10.1016/j.jchemneu.2019.01.011 Intrathecal transplantation of Wharton’s jelly mesenchymal stem cells suppresses the NLRP1 inflammasome in the rat model of spinal cord injury
Biomed. Res. Int. Pawitan 2014 965849 2014 10.1155/2014/965849 Prospect of stem cell conditioned medium in regenerative medicine
J. Neurol. Sci. Pluchino 265 1 105 2008 10.1016/j.jns.2007.07.020 The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis
Leukemia Ratajczak 26 6 1166 2012 10.1038/leu.2011.389 Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?
Neural. Regen. Res. Ryu 11 2 298 2016 10.4103/1673-5374.177739 Human neural stem cells promote proliferation of endogenous neural stem cells and enhance angiogenesis in ischemic rat brain
Neural. Regen. Res. Sampaio 12 4 549 2017 10.4103/1673-5374.205084 Neurotrophic factors in Alzheimer’s and Parkinson’s diseases: implications for pathogenesis and therapy
J. Neuroimmunol. Sarchielli 132 1-2 180 2002 10.1016/S0165-5728(02)00319-3 Brain-derived neurotrophic factor in patients with multiple sclerosis
Sarkar 259 2016 Translational Neuroscience Stem cells for multiple sclerosis
Brain Res. Scalabrino 1333 64 2010 10.1016/j.brainres.2010.03.073 Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis
Brain Scolding 140 11 2776 2017 10.1093/brain/awx154 Cell-based therapeutic strategies for multiple sclerosis
Cold Spring Harb. Perspect. Biol. Simons 8 1 a020479 2016 10.1101/cshperspect.a020479 Oligodendrocytes: myelination and axonal support
CNS Neurosci. Ther. Tang 21 4 337 2015 10.1111/cns.12386 Opportunities and challenges: stem cellbased therapy for the treatment of ischemic stroke
N. Engl. J. Med. Trapp 338 5 278 1998 10.1056/NEJM199801293380502 Axonal transection in the lesions of multiple sclerosis
Prog. Brain Res. Villoslada 146 403 2004 10.1016/S0079-6123(03)46025-1 Role of nerve growth factor and other trophic factors in brain inflammation
J. Neurosci. VonDran 31 40 14182 2011 10.1523/JNEUROSCI.6595-10.2011 Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion
Neurologic Clinics Wu 29 2 2011 10.1016/j.ncl.2010.12.009 The immuno-pathophysiology of multiple sclerosis
Mol. Neurobiol. Xiao 55 4 3152 2018 10.1007/s12035-017-0566-7 Neural stem cell-based regenerative approaches for the treatment of multiple sclerosis
Stem Cells Int. Yang 2018 2018 10.1155/2018/4659159 Neural stem cell-conditioned medium ameliorated cerebral ischemia-reperfusion injury in rats
Immunol. Lett. Yousefi 172 94 2016 10.1016/j.imlet.2016.02.016 In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.